These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6195476)

  • 1. Effects of two alpha-adrenoceptor antagonists, nicergoline and phentolamine, on myocardial oxygen consumption in the dog.
    Lièvre M; Kofman J; Andrieu JL; Faucon G
    J Cardiovasc Pharmacol; 1983; 5(5):856-60. PubMed ID: 6195476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some haemodynamic effects of nicergoline, a new alpha-blocking agent, in the closed-chest anaesthetized dog as compared with nitroprusside and nitroglycerin.
    Moore ND; Cazor JL; Leclerc JL; Saligaut C; Boismare F
    Arzneimittelforschung; 1981; 31(10):1693-8. PubMed ID: 6797441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myometrial responses in situ to nicergoline, acebutolol, phentolamine and noradrenaline of the rat in proestrus.
    Acritopoulou-Fourcroy S; Clabaut M; Schrub JC
    Eur J Pharmacol; 1984 Dec; 107(1):59-64. PubMed ID: 6543175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentiation by an alpha-adrenolytic agent, nicergoline, of the cardiac effects of propranolol.
    Boismare F; Moore N; Decourt S; Paux G; Saligaut C; Chretien P
    Methods Find Exp Clin Pharmacol; 1983; 5(2):83-8. PubMed ID: 6876944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nicergoline on the cardiovascular system of dogs and rats.
    Huchet AM; Mouillé P; Chelly J; Lucet B; Doursout MF; Lechat P; Schmitt H
    J Cardiovasc Pharmacol; 1981; 3(4):677-91. PubMed ID: 6167799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of alpha-adrenoceptor antagonists (phentolamine, nicergoline and prazosin) on reperfusion arrhythmias and noradrenaline release in perfused rat heart.
    Bralet J; Didier J; Moreau D; Opie LH; Rochette L
    Br J Pharmacol; 1985 Jan; 84(1):9-18. PubMed ID: 2858234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centrally mediated cardiovascular effects of nicergoline in the dog compared to those of clonidine.
    Lièvre M; Morin MH; Lakhal M; Faucon G
    Eur J Pharmacol; 1985 Oct; 117(1):103-7. PubMed ID: 4085539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of nicergoline on the cerebral blood flow and alpha-sympatholytical properties (author's transl)].
    Lievre M; Ollagnier M; Faucon G
    Arzneimittelforschung; 1979; 29(8a):1227-31. PubMed ID: 44198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary blood flow and myocardial oxygen consumption after alpha adrenergic blockade during submaximal exercise.
    Gwirtz PA; Stone HL
    J Pharmacol Exp Ther; 1981 Apr; 217(1):92-8. PubMed ID: 6110777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of the alpha-adrenergic antagonist nicergoline during acute myocardial ischemia and reperfusion in the dog.
    Bolli R; Brandon TA; Fisher DJ; Fernandez GC; Miller RR
    Am Heart J; 1983 Nov; 106(5 Pt 1):1014-23. PubMed ID: 6416040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological study of nicergoline. Effects on regional cerebral blood flows and arterial carbon dioxide and oxygen pressure and pH in rats under cyanide-induced histotoxic anoxia.
    Shintomi K
    Arzneimittelforschung; 1991 Sep; 41(9):885-90. PubMed ID: 1796914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effects of nicergoline on the heart rate in the normotensive or spontaneously hypertensive rat. Possible participation of central alpha-1 receptors].
    Huchet AM; Schmitt H
    J Pharmacol; 1986; 17(1):53-9. PubMed ID: 3012204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of nicergoline on the lower urinary tract muscle.
    Caine M; Mazouz B; Rossini BM
    Urol Res; 1984; 12(6):287-90. PubMed ID: 6151755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of an alpha-1-adrenoceptor antagonist, nicergoline, on placental prostanoid production in streptozotocin-induced diabetic pregnant rats.
    Chartrel N; Clabaut M; Boismare F; Schrub JC
    Biol Neonate; 1990; 57(3-4):218-23. PubMed ID: 1969751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do alterations in prostanoid or catecholamine release influence the antiarrhythmic activity of nicergoline?
    Williams FM; Coker SJ; Dean HG; Kane KA; Parratt JR
    J Cardiovasc Pharmacol; 1986; 8(2):286-93. PubMed ID: 2422466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-adrenoceptor-mediated coronary vasoconstriction is augmented during exercise in experimental diabetes mellitus.
    Setty S; Sun W; Martinez R; Downey HF; Tune JD
    J Appl Physiol (1985); 2004 Jul; 97(1):431-8. PubMed ID: 14978008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic, insulin, and work interactions with adenosine's effects on in situ myocardial glucose uptake.
    Law WR; McLane MP
    Cardiovasc Res; 1996 May; 31(5):691-8. PubMed ID: 8763398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained ventricular unloading action of the alpha-adrenergic antagonist nicergoline in the dog.
    Payen DM; Blanloeil YA; Pinaud ML; Lucas B
    Crit Care Med; 1985 Aug; 13(8):656-60. PubMed ID: 3893889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intravenous infusion of an alpha-adrenergic blocking agent on the haemodynamic changes in human masseter muscle induced by cold pressor stimulation.
    Maekawa K; Kuboki T; Miyawaki T; Shimada M; Yamashita A; Clark GT
    Arch Oral Biol; 1999 Apr; 44(4):319-27. PubMed ID: 10348358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.